Transferrin Receptor Binding BBB-Shuttle Facilitates Brain Delivery of Anti-Aβ-Affibodies

Affibodies targeting amyloid-beta (Aβ) could potentially be used as therapeutic and diagnostic agents in Alzheimer’s disease (AD). Affibodies display suitable characteristics for imaging applications such as high stability and a short biological half-life. The aim of this study was to explore brain...

Descripción completa

Detalles Bibliográficos
Autores principales: Faresjö, Rebecca, Lindberg, Hanna, Ståhl, Stefan, Löfblom, John, Syvänen, Stina, Sehlin, Dag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246779/
https://www.ncbi.nlm.nih.gov/pubmed/35538266
http://dx.doi.org/10.1007/s11095-022-03282-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246779/
https://www.ncbi.nlm.nih.gov/pubmed/35538266
http://dx.doi.org/10.1007/s11095-022-03282-2

Ejemplares similares